Richard Francis, Teva CEO

Te­va to close ad­di­tion­al man­u­fac­tur­ing sites as it en­ters next phase of 'piv­ot to growth'

Te­va is get­ting ready to close the first chap­ter of its “piv­ot to growth” strat­e­gy.

The com­pa­ny’s re­struc­tur­ing has in­volved man­u­fac­tur­ing site clo­sures, a shift away from some low­er-mar­gin gener­ics, and more re­cent­ly, plans to sell off its API unit. The first quar­ter of 2024 marked Te­va’s fourth con­sec­u­tive quar­ter of rev­enue growth, CEO Richard Fran­cis told in­vestors on Wednes­day, as he looks to­ward the next phase in the strat­e­gy.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.